Copyright Reports & Markets. All rights reserved.

Global Insomnia Pharmacological Treatment Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Global Insomnia Pharmacological Treatment Market Research Report 2018

      1 Insomnia Pharmacological Treatment Market Overview

      • 1.1 Product Overview and Scope of Insomnia Pharmacological Treatment
      • 1.2 Insomnia Pharmacological Treatment Segment by Type (Product Category)
        • 1.2.1 Global Insomnia Pharmacological Treatment Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
        • 1.2.2 Global Insomnia Pharmacological Treatment Production Market Share by Type (Product Category) in 2017
        • 1.2.3 Prescription Sleep Aids
        • 1.2.3 Over-the-Counter Sleep Aids
      • 1.3 Global Insomnia Pharmacological Treatment Segment by Application
        • 1.3.1 Insomnia Pharmacological Treatment Consumption (Sales) Comparison by Application (2013-2025)
        • 1.3.2 Homecare
        • 1.3.3 Clinic
        • 1.3.4 Hospital
      • 1.4 Global Insomnia Pharmacological Treatment Market by Region (2013-2025)
        • 1.4.1 Global Insomnia Pharmacological Treatment Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
        • 1.4.2 North America Status and Prospect (2013-2025)
        • 1.4.3 Europe Status and Prospect (2013-2025)
        • 1.4.4 China Status and Prospect (2013-2025)
        • 1.4.5 Japan Status and Prospect (2013-2025)
        • 1.4.6 Southeast Asia Status and Prospect (2013-2025)
        • 1.4.7 India Status and Prospect (2013-2025)
      • 1.5 Global Market Size (Value) of Insomnia Pharmacological Treatment (2013-2025)
        • 1.5.1 Global Insomnia Pharmacological Treatment Revenue Status and Outlook (2013-2025)
        • 1.5.2 Global Insomnia Pharmacological Treatment Capacity, Production Status and Outlook (2013-2025)

      2 Global Insomnia Pharmacological Treatment Market Competition by Manufacturers

      • 2.1 Global Insomnia Pharmacological Treatment Capacity, Production and Share by Manufacturers (2013-2018)
        • 2.1.1 Global Insomnia Pharmacological Treatment Capacity and Share by Manufacturers (2013-2018)
        • 2.1.2 Global Insomnia Pharmacological Treatment Production and Share by Manufacturers (2013-2018)
      • 2.2 Global Insomnia Pharmacological Treatment Revenue and Share by Manufacturers (2013-2018)
      • 2.3 Global Insomnia Pharmacological Treatment Average Price by Manufacturers (2013-2018)
      • 2.4 Manufacturers Insomnia Pharmacological Treatment Manufacturing Base Distribution, Sales Area and Product Type
      • 2.5 Insomnia Pharmacological Treatment Market Competitive Situation and Trends
        • 2.5.1 Insomnia Pharmacological Treatment Market Concentration Rate
        • 2.5.2 Insomnia Pharmacological Treatment Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Insomnia Pharmacological Treatment Capacity, Production, Revenue (Value) by Region (2013-2018)

      • 3.1 Global Insomnia Pharmacological Treatment Capacity and Market Share by Region (2013-2018)
      • 3.2 Global Insomnia Pharmacological Treatment Production and Market Share by Region (2013-2018)
      • 3.3 Global Insomnia Pharmacological Treatment Revenue (Value) and Market Share by Region (2013-2018)
      • 3.4 Global Insomnia Pharmacological Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.5 North America Insomnia Pharmacological Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.6 Europe Insomnia Pharmacological Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.7 China Insomnia Pharmacological Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.8 Japan Insomnia Pharmacological Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.9 Southeast Asia Insomnia Pharmacological Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.10 India Insomnia Pharmacological Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

      4 Global Insomnia Pharmacological Treatment Supply (Production), Consumption, Export, Import by Region (2013-2018)

      • 4.1 Global Insomnia Pharmacological Treatment Consumption by Region (2013-2018)
      • 4.2 North America Insomnia Pharmacological Treatment Production, Consumption, Export, Import (2013-2018)
      • 4.3 Europe Insomnia Pharmacological Treatment Production, Consumption, Export, Import (2013-2018)
      • 4.4 China Insomnia Pharmacological Treatment Production, Consumption, Export, Import (2013-2018)
      • 4.5 Japan Insomnia Pharmacological Treatment Production, Consumption, Export, Import (2013-2018)
      • 4.6 Southeast Asia Insomnia Pharmacological Treatment Production, Consumption, Export, Import (2013-2018)
      • 4.7 India Insomnia Pharmacological Treatment Production, Consumption, Export, Import (2013-2018)

      5 Global Insomnia Pharmacological Treatment Production, Revenue (Value), Price Trend by Type

      • 5.1 Global Insomnia Pharmacological Treatment Production and Market Share by Type (2013-2018)
      • 5.2 Global Insomnia Pharmacological Treatment Revenue and Market Share by Type (2013-2018)
      • 5.3 Global Insomnia Pharmacological Treatment Price by Type (2013-2018)
      • 5.4 Global Insomnia Pharmacological Treatment Production Growth by Type (2013-2018)

      6 Global Insomnia Pharmacological Treatment Market Analysis by Application

      • 6.1 Global Insomnia Pharmacological Treatment Consumption and Market Share by Application (2013-2018)
      • 6.2 Global Insomnia Pharmacological Treatment Consumption Growth Rate by Application (2013-2018)
      • 6.3 Market Drivers and Opportunities
        • 6.3.1 Potential Applications
        • 6.3.2 Emerging Markets/Countries

      7 Global Insomnia Pharmacological Treatment Manufacturers Profiles/Analysis

      • 7.1 Eisai, Co. Ltd. (Japan)
        • 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.1.2 Insomnia Pharmacological Treatment Product Category, Application and Specification
          • 7.1.2.1 Product A
          • 7.1.2.2 Product B
        • 7.1.3 Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.1.4 Main Business/Business Overview
      • 7.2 Merck & Co., Inc. (U.S.)
        • 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.2.2 Insomnia Pharmacological Treatment Product Category, Application and Specification
          • 7.2.2.1 Product A
          • 7.2.2.2 Product B
        • 7.2.3 Merck & Co., Inc. (U.S.) Insomnia Pharmacological Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.2.4 Main Business/Business Overview
      • 7.3 Meda Consumer Healthcare Inc. (U.S.)
        • 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.3.2 Insomnia Pharmacological Treatment Product Category, Application and Specification
          • 7.3.2.1 Product A
          • 7.3.2.2 Product B
        • 7.3.3 Meda Consumer Healthcare Inc. (U.S.) Insomnia Pharmacological Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.3.4 Main Business/Business Overview
      • 7.4 Pfizer, Inc. (U.S.)
        • 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.4.2 Insomnia Pharmacological Treatment Product Category, Application and Specification
          • 7.4.2.1 Product A
          • 7.4.2.2 Product B
        • 7.4.3 Pfizer, Inc. (U.S.) Insomnia Pharmacological Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.4.4 Main Business/Business Overview
      • 7.5 Sanofi (France)
        • 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.5.2 Insomnia Pharmacological Treatment Product Category, Application and Specification
          • 7.5.2.1 Product A
          • 7.5.2.2 Product B
        • 7.5.3 Sanofi (France) Insomnia Pharmacological Treatment Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
        • 7.5.4 Main Business/Business Overview
      • 7.6 Takeda Pharmaceutical Company Ltd. (Japan)
        • 7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.6.2 Insomnia Pharmacological Treatment Product Category, Application and Specification
          • 7.6.2.1 Product A
          • 7.6.2.2 Product B
        • 7.6.3 Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.6.4 Main Business/Business Overview
      • 7.7 Pernix Therapeutics (U.S.)
        • 7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.7.2 Insomnia Pharmacological Treatment Product Category, Application and Specification
          • 7.7.2.1 Product A
          • 7.7.2.2 Product B
        • 7.7.3 Pernix Therapeutics (U.S.) Insomnia Pharmacological Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.7.4 Main Business/Business Overview
      • 7.8 Purdue Pharma L.P. (U.S.)
        • 7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.8.2 Insomnia Pharmacological Treatment Product Category, Application and Specification
          • 7.8.2.1 Product A
          • 7.8.2.2 Product B
        • 7.8.3 Purdue Pharma L.P. (U.S.) Insomnia Pharmacological Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.8.4 Main Business/Business Overview

      8 Insomnia Pharmacological Treatment Manufacturing Cost Analysis

      • 8.1 Insomnia Pharmacological Treatment Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
        • 8.1.4 Market Concentration Rate of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
        • 8.2.1 Raw Materials
        • 8.2.2 Labor Cost
        • 8.2.3 Manufacturing Expenses
      • 8.3 Manufacturing Process Analysis of Insomnia Pharmacological Treatment

      9 Industrial Chain, Sourcing Strategy and Downstream Buyers

      • 9.1 Insomnia Pharmacological Treatment Industrial Chain Analysis
      • 9.2 Upstream Raw Materials Sourcing
      • 9.3 Raw Materials Sources of Insomnia Pharmacological Treatment Major Manufacturers in 2017
      • 9.4 Downstream Buyers

      10 Marketing Strategy Analysis, Distributors/Traders

      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
        • 10.1.3 Marketing Channel Development Trend
      • 10.2 Market Positioning
        • 10.2.1 Pricing Strategy
        • 10.2.2 Brand Strategy
        • 10.2.3 Target Client
      • 10.3 Distributors/Traders List

      11 Market Effect Factors Analysis

      • 11.1 Technology Progress/Risk
        • 11.1.1 Substitutes Threat
        • 11.1.2 Technology Progress in Related Industry
      • 11.2 Consumer Needs/Customer Preference Change
      • 11.3 Economic/Political Environmental Change

      12 Global Insomnia Pharmacological Treatment Market Forecast (2018-2025)

      • 12.1 Global Insomnia Pharmacological Treatment Capacity, Production, Revenue Forecast (2018-2025)
        • 12.1.1 Global Insomnia Pharmacological Treatment Capacity, Production and Growth Rate Forecast (2018-2025)
        • 12.1.2 Global Insomnia Pharmacological Treatment Revenue and Growth Rate Forecast (2018-2025)
        • 12.1.3 Global Insomnia Pharmacological Treatment Price and Trend Forecast (2018-2025)
      • 12.2 Global Insomnia Pharmacological Treatment Production, Consumption , Import and Export Forecast by Region (2018-2025)
        • 12.2.1 North America Insomnia Pharmacological Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.2 Europe Insomnia Pharmacological Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.3 China Insomnia Pharmacological Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.4 Japan Insomnia Pharmacological Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.5 Southeast Asia Insomnia Pharmacological Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.6 India Insomnia Pharmacological Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
      • 12.3 Global Insomnia Pharmacological Treatment Production, Revenue and Price Forecast by Type (2018-2025)
      • 12.4 Global Insomnia Pharmacological Treatment Consumption Forecast by Application (2018-2025)

      13 Research Findings and Conclusion

        14 Appendix

        • 14.1 Methodology/Research Approach
          • 14.1.1 Research Programs/Design
          • 14.1.2 Market Size Estimation
          • 14.1.3 Market Breakdown and Data Triangulation
        • 14.2 Data Source
          • 14.2.1 Secondary Sources
          • 14.2.2 Primary Sources

        This report studies the global Insomnia Pharmacological Treatment market status and forecast, categorizes the global Insomnia Pharmacological Treatment market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

        The major manufacturers covered in this report
        Eisai, Co. Ltd. (Japan)
        Merck & Co., Inc. (U.S.)
        Meda Consumer Healthcare Inc. (U.S.)
        Pfizer, Inc. (U.S.)
        Sanofi (France)
        Takeda Pharmaceutical Company Ltd. (Japan)
        Pernix Therapeutics (U.S.)
        Purdue Pharma L.P. (U.S.)

        Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        We can also provide the customized separate regional or country-level reports, for the following regions:
        North America
        United States
        Canada
        Mexico
        Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Rest of Asia-Pacific
        Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
        Central & South America
        Brazil
        Argentina
        Rest of South America
        Middle East & Africa
        Saudi Arabia
        Turkey
        Rest of Middle East & Africa

        On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
        Prescription Sleep Aids
        Over-the-Counter Sleep Aids
        On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
        Homecare
        Clinic
        Hospital

        The study objectives of this report are:
        To analyze and study the global Insomnia Pharmacological Treatment capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
        Focuses on the key Insomnia Pharmacological Treatment manufacturers, to study the capacity, production, value, market share and development plans in future.
        Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
        To define, describe and forecast the market by type, application and region.
        To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
        To identify significant trends and factors driving or inhibiting the market growth.
        To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
        To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
        To strategically profile the key players and comprehensively analyze their growth strategies.

        In this study, the years considered to estimate the market size of Insomnia Pharmacological Treatment are as follows:
        History Year: 2013-2017
        Base Year: 2017
        Estimated Year: 2018
        Forecast Year 2018 to 2025

        For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

        Key Stakeholders
        Insomnia Pharmacological Treatment Manufacturers
        Insomnia Pharmacological Treatment Distributors/Traders/Wholesalers
        Insomnia Pharmacological Treatment Subcomponent Manufacturers
        Industry Association
        Downstream Vendors

        Available Customizations
        With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
        Regional and country-level analysis of the Insomnia Pharmacological Treatment market, by end-use.
        Detailed analysis and profiles of additional market players.

        Buy now